Prof. Wei Cui | Immunology | Best Researcher Award
Researcher | National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | China
Prof. Wei Cui is a distinguished researcher and academic leader in the field of clinical diagnostics and oncology. She currently serves as Vice President of Henan Hospital and Director of the Department of Clinical Laboratory at the Cancer Hospital, Chinese Academy of Medical Sciences. With over three decades of progressive experience, Prof. Cui has become a national authority in tumor immunology, liquid biopsy, and diagnostic standardization. Her career bridges advanced medical research and practical application, contributing significantly to the evolution of cancer diagnosis and treatment in China.
Professional Profile
🎓 Education
Prof. Cui began her academic journey with a Bachelor’s degree in Clinical Medicine from Harbin Medical University. She further pursued a Master’s degree in Experimental Diagnostics and a Ph.D. in Internal Medicine Oncology, both from the prestigious Peking Union Medical College. To enhance her global perspective, she completed postdoctoral training at Harvard University’s Children’s Hospital Boston, focusing on advanced clinical and laboratory research methodologies.
💼 Experience
Her professional trajectory spans over 30 years, starting as a physician at the First Affiliated Hospital of Harbin Medical University. She progressed through multiple research and clinical roles at Peking Union Medical College Hospital before moving into leadership positions at the Cancer Hospital of the Chinese Academy of Medical Sciences. Since 2024, she has been serving as Vice President at Henan Hospital, while continuing her research and administrative duties. Her roles have evolved from assistant researcher to department director and now, institutional leader, underscoring her commitment to scientific excellence and clinical innovation.
🔬 Research Interests
Prof. Cui’s core research lies in tumor biomarker discovery, circulating tumor cells (CTC) detection, tumor immune microenvironment, and personalized cancer diagnostics. She has led numerous high-impact research projects funded by the National Natural Science Foundation of China and the Ministry of Science and Technology. Her work emphasizes translational medicine, bridging the gap between laboratory breakthroughs and clinical practice, especially in immunotherapy and cancer screening technologies.
🏆 Honors
Prof. Cui has received numerous national honors, including the Huaxia Medical Science and Technology Award and the Science and Technology Awards from the Chinese Preventive Medicine Association and the Chinese Medical Association. She has also been a key contributor to the development of national clinical standards, issuing multiple authoritative guidelines under the Ministry of Health and professional medical societies. Her innovations in diagnostic methods have been granted national patents, reflecting her impact on both scientific and practical aspects of cancer care.
📚 Top Noted Publications
Title: A Wireless Cytosensor Based on a Bionic Dandelion Isothermal Amplification System for Ultrasensitive Detection of Circulating Tumor Cells
Journal: ACS Nano
Year of Publication: 2025
Title: The Degree of Refinement of Immune Cell Subsets Detection by Multi-Parameter Flow Cytometry Should Advance with the Times
Type: Review
Year of Publication: 2025
Title: Single Circulating Tumor Cell Sequencing Based on Improved High-Porosity Membranes and Nanoporous Microchambers
Journal: Biosensors and Bioelectronics
Year of Publication: 2025
Title: ALKBH5-Mediated m6A Regulates the Alternative Splicing Events of SRSF10 in Ovarian Cancer
Journal: Cancer Gene Therapy
Year of Publication: 2025
Title: External Quality Assessment-Based Tumor Marker Harmonization Simulation; Insights in Achievable Harmonization for CA 15-3 and CEA
Journal: Clinical Chemistry and Laboratory Medicine
Year of Publication: 2025
Title: Global Research Trends of Immunosenescence and Immunotherapy: A Bibliometric Study
Journal: Human Vaccines & Immunotherapeutics
Year of Publication: 2025
Citations: 1
Conclusion
Prof. Wei Cui stands at the forefront of clinical oncology research in China, combining scientific rigor with a vision for practical healthcare impact. Her work has advanced cancer diagnostics, established national clinical standards, and fostered interdisciplinary collaboration. With continued dedication and innovation, Prof. Cui remains a vital force in shaping the future of precision medicine and public health diagnostics.